4DMedical is trading at A$4.46, up 5.69%, with the reason for the October 12, 2026 rise unclear. - No confirmed company announcement or specific catalyst explaining the rise was identified; available coverage does not link short-selling discussion to the move. - The supplied market context shows major U.S. indices nearly flat, offering no established broader-market explanation. The gain should not be attributed to unrelated prior company news or general market sentiment without stronger evidence.